Skip to main content
Equibles

4582 · SymBio Pharmaceuticals Limited · Financials

Use 4582 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4582.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
54 JPY -2 (-3.57%) At close · Nov 11
Rebalance outlook locked
Market Cap
4.33B JPY
Shares
80.16M
Volume · Nov 11 4.41M Avg daily vol (3M) 2.99M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
1.31B -46.7%
FY2025 Revenue FY2021–FY2025
Net Income
-4.78B -24.6%
FY2025 Net Income FY2021–FY2025
Gross Margin
72.45% -3.9pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-339.59% -181.5pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-4.58B -33.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 1.31B 2.45B 5.59B 10.01B 8.26B
JPY 360.31M 579.72M 1.18B 2.41B —
JPY 947.34M 1.87B 4.41B 7.6B 5.8B
JPY -4.44B -3.88B -811.67M 1.96B 1.02B
JPY -4.75B -3.81B -1.2B 2.11B 1B
JPY 27.57M 26.52M 767.43M 927.04M -1.03B
JPY -4.78B -3.83B -1.96B 1.18B 2.03B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.